Literature DB >> 18486756

Strategies and technical challenges in allele level Class II typing in 2578 bone marrow transplantation donor-recipient pairs.

T M Williams1, T Winden, M Setterholm, C A Vierra-Green, S Spellman, S Flesch, Z Awdeh, L A Baxter-Lowe, A B Begovich, M Fernandez-Vina, J Hegland, C K Hurley, D Johnson, H Noreen, M Salazar, B Schmeckpeper, E J Yunis.   

Abstract

Human leukocyte antigen typing of 2578 donor-recipient pairs whose transplantation was facilitated by the National Marrow Donor Program allowed for an in-depth analysis of the accuracy of high-volume allele level testing data. The methods employed provided allele level typing at DRB1/3/5, DQA1, DQB1, DPA1, and DPB1 using sequence-specific oligonucleotide probe hybridization (SSOPH), polymerase chain reaction (PCR) restriction fragment length polymorphism analysis, sequence specific PCR, and direct sequence-based typing (SBT). Each typing was independently tested by two laboratories in Phase 1, and in subsequent phases targeted samples were typed in duplicate by SBT to monitor typing quality. Comparison with prior transplant center typing was also evaluated. SSOPH detected discrepancies ranged from 0.6% at DPB1 to 5.1% at DQB1 in Phase 1. The majority of discrepancies, 62%, resulted from human error such as sample handling, result interpretation, or clerical errors. Alleles that are frequently discrepant have been identified in this predominantly white population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18486756     DOI: 10.1016/j.humimm.2008.03.004

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  1 in total

1.  A combined DPA1~DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer.

Authors:  Jill A Hollenbach; Abeer Madbouly; Loren Gragert; Cynthia Vierra-Green; Susan Flesch; Stephen Spellman; Ann Begovich; Harriet Noreen; Elizabeth Trachtenberg; Tom Williams; Neng Yu; Bronwen Shaw; Katharina Fleischhauer; Marcelo Fernandez-Vina; Martin Maiers
Journal:  Immunogenetics       Date:  2012-04-13       Impact factor: 2.846

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.